Clinical Trial Update: Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical trial evaluating a chemogenetic gene therapy using an AAV vector for Parkinson's disease, delivered via stereotactic surgery to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Parkinson's Disease (PD) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING